Is pharmaceutical innovation declining?: interpreting measures of pharmaceutical innovation and regulatory impact in the USA, 1950-1980
Wardell, W.M.; Sheck, L.E.
Rational Drug Therapy 17(1): 1-7
1983
ISSN/ISBN: 0031-7020 PMID: 6340163 Accession: 043472408
Full Text Article emailed within 1 workday: $29.90
Related References
Honig, P.; Zhang, L. 2019: Regulation and Innovation: Role of Regulatory Science in Facilitating Pharmaceutical Innovation Clinical Pharmacology and Therapeutics 105(4): 778-781Sethi, D.; Chaturvedi, V.; Sethi, A. 2021: Innovation in Indian Pharmaceutical Industry: Impact of Changing Regulatory Regime Journal of Pharmaceutical Research International: 187-196
Karampli, E.; Souliotis, K.; Polyzos, N.; Kyriopoulos, J.; Chatzaki, E. 2014: Pharmaceutical innovation: impact on expenditure and outcomes and subsequent challenges for pharmaceutical policy, with a special reference to Greece Hippokratia 18(2): 100-106
Dionne, P.-A.; Ali, F.; Grobler, M. 2015: The Impact of Recent Generic Drug Price Policies on Pharmaceutical Innovation: a Theoretical Rationale and Proposal of a Method Supporting Innovation in Areas of Unmet Medical Need Journal of Health Economics and Outcomes Research 3(1): 13-23
Schmid, E.F.; Smith, D.A. 2005: Keynote review: Is declining innovation in the pharmaceutical industry a myth? Drug Discovery Today 10(15): 1031-1039
Varol, N.; Costa-Font, J.; McGuire, A. 2012: Does Adoption of Pharmaceutical Innovation Respond to Changes in the Regulatory Environment? Applied Economic Perspectives and Policy 34(3): 531-553
Hebert, G.; Protlabarthe, S.; Tremblay, M.E.; Bussieres, J.F.; Bourdon, O. 2014: La pédiatrie, toujours exclue de l'innovation pharmaceutique ? - Is pediatrics excluded from pharmaceutical innovation? Archives de Pediatrie (Paris) 21(3): 245-250
Grognet, J.M. 2003: L'innovation pharmaceutique marque-t-elle le pas ? : Le médicament est-il malade ? - Pharmaceutical innovation Biofutur (Puteaux) 239: 20-22
Moreno, S.G.; Epstein, D. 2019: The price of innovation - the role of drug pricing in financing pharmaceutical innovation. A conceptual framework Journal of Market Access and Health Policy 7(1): 1583536
Aagaard, A. 2012: The Contribution of Innovation Strategy Development and Implementation in Active Facilitation of Pharmaceutical Front End Innovation Systemic Practice and Action Research 25(6): 457-477
Barei, F.; Le Pen, C.; Simoens, S. 2013: The generic pharmaceutical industry : moving beyond incremental innovation towards re-innovation Gabi Journals : Generics and Biosimilars Initiative Journal 2(1): 13-19
Cavara, C. 1991: Product innovation in the pharmaceutical sector. IV. Internationalization and technologic innovation Bollettino Chimico Farmaceutico 130(11): 458-467
Dimasi, J.A. 2000: New drug innovation and pharmaceutical industry structure : Trends in the output of pharmaceutical firms Drug Information Journal 34(4): 1169-1194
Rothberg, R.R. 2005: Leading Pharmaceutical Innovation: Trends and Drivers for Growth in the Pharmaceutical Industry Journal of Product Innovation Management 22(2): 219-220
Robberson, M.; Breder, C.D. 2021: A Multifaceted Perspective of Pharmaceutical Innovation: a Consideration of the Regulatory Role Therapeutic Innovation and Regulatory Science 55(2): 262-269
Lipworth, W. 2015: Pharmaceutical Ethics Comes to Life in Therapeutic Innovation and Regulatory Science Therapeutic Innovation and Regulatory Science 49(3): 324-325
Xia, Y.; Fan, M.; Zuo, X.; Hao, W.; Jia, Y. 2022: Government innovation subsidy, executives' academic capital and innovation quality: Evidence from pharmaceutical companies in China Frontiers in Psychology 13: 1092162
Song, C.H.; Leker, J. 2018: Differentiation of innovation strategies based on pharmaceutical licensing agreements: Insight from Korean pharmaceutical firms Technology Analysis-Strategic Management 31(2): 169-185
Prentis, R.A.; Lis, Y.; Walker, S.R. 1988: Pharmaceutical innovation by the seven UK-owned pharmaceutical companies (1964-1985) British Journal of Clinical Pharmacology 25(3): 387-396
Wertheimer, A I.; Bootman, J. Lyle 1977: The Social Impact of Pharmaceutical Innovation Drug Development and Industrial Pharmacy 3(3): 219-225